Invitation to presentation of Electrolux Group Q4 report

Invitation to presentation of Electrolux Group Q4 report

STOCKHOLM, Jan. 15, 2026 /PRNewswire/ -- On 30th of January, 2026, Electrolux Group will publish the results for the fourth quarter of 2025, at approx. 07.00 CET. Media, investors and analysts are invited to a simultaneous video webcast and...

KCM Trade Unveils Research Report Series

KCM Trade Unveils Research Report Series

Empowering Global Investors with Expert Market Intelligence HONG KONG, Jan. 14, 2026 /PRNewswire/ -- KCM Trade, a global leading Contract for Difference (CFD) broker, today announced the launch of its proprietary research report series with the...

SKF to publish Q4 report on 30 January

SKF to publish Q4 report on 30 January

GOTHENBURG, Sweden, Jan. 13, 2026 /PRNewswire/ -- SKF will publish its Q4 results for 2025 on 30 January at approximately 07:30 (CET). Investors, analysts and media are invited to join an audio webcast, which will be held in English, at 09:00 (CET)....

Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference

Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference

MELBOURNE, Australia and INDIANAPOLIS, Jan. 8, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today advises that Dr. Christian Behrenbruch, Managing Director and Group CEO, will be presenting at the 44th Annual...

Invitation to Autoliv's Q4, 2025 Earnings Call

Invitation to Autoliv's Q4, 2025 Earnings Call

STOCKHOLM , Jan. 8, 2026 /PRNewswire/ -- Autoliv Inc., plans to publish its Financial Report for the fourth quarter 2025 on Friday, January 30, 2026 at 12:00 Central European Time (CET). The report will be available at www.autoliv.com In addition, a...

EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide

EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide

PROVIDENCE, R.I., Dec. 9, 2025 /PRNewswire/ -- EpiVax, Inc., with U.S. Food and Drug Administration (FDA) and CUBRC, Inc. (Buffalo, NY) scientist collaborators, announces the publication of a study titled "Immunogenicity Risk Assessment of...

Invitation to Minesto's webinar: Interim Management Statement Q3

Invitation to Minesto's webinar: Interim Management Statement Q3

GOTHENBURG, Sweden and VÄSTRA GÖTALAND, Sweden, Nov. 25, 2025 /PRNewswire/ -- On Thursday November 27, Minesto, leading ocean energy developer, will publish the Interim Management Statement 1 January - 30 September 2025. Dr Martin Edlund, CEO, will...

Invitation to Autoliv's Q2, 2025 Earnings Call

Invitation to Autoliv's Q2, 2025 Earnings Call

STOCKHOLM, June 18, 2025 /PRNewswire/ -- Autoliv Inc., plans to publish its Financial Report for the second quarter 2025 on Friday, July 18, 2025 at 12:00 Central European Time (CET). The report will be available at www.autoliv.com In addition, a...

Project InnerSpace Launches Initiative to Accelerate Geothermal Development in Indonesia

Project InnerSpace Launches Initiative to Accelerate Geothermal Development in Indonesia

Geothermal has the potential to unlock vast amounts of affordable, reliable, and clean energy and heat, becoming a vital part of Indonesia's energy security and economic development JAKARTA, Indonesia , June 3, 2025 /PRNewswire/ -- Project...

Aker Horizons ASA: Invitation to presentation of first-quarter results 2025

Aker Horizons ASA: Invitation to presentation of first-quarter results 2025

FORNEBU, Norway, April 30, 2025 /PRNewswire/ -- Aker Horizons (OSE: AKH) will publish its financial results for the first quarter 2025 on Thursday 8 May 2025, at 07:00 CEST. An online presentation of the results will be held on the same day at 08:30...

  • 1
  • 2
  • menu
    menu